CTOs on the Move


 
JenCare Senior Medical Centers are family-owned primary and specialty care practices committed to delivering superior healthcare to Medicare-eligible seniors. Our care model now serves tens of thousands of seniors all across the country. And we`ll continue to expand to offer more seniors access to the quality healthcare they deserve.
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Cornerstone Specialty Network

Cornerstone Specialty Network is a company that provides value to community-based oncology practices through network aggregation, delivering value-added opportunities that support independence and long-term sustainability for community oncology practices.

Senior Home Care

Senior Home Care offers the full range of covered Medicare Certified Home Health Services throughout Florida. For more information about Senior Home Care, please contact us at: Senior Home Care, Inc.

Corwin Medical Care

Corwin Medical Care is a Plainfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Howard County General Hospital

Howard County General Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Howard County General Hospital is based in Columbia, MD. You can find more information on Howard County General Hospital at www.hcgh.org

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.